171 related articles for article (PubMed ID: 32171935)
21. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
Snoek BC; Verlaat W; Babion I; Novianti PW; van de Wiel MA; Wilting SM; van Trommel NE; Bleeker MCG; Massuger LFAG; Melchers WJG; Sie D; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM
Int J Cancer; 2019 Jan; 144(2):372-379. PubMed ID: 30192375
[TBL] [Abstract][Full Text] [Related]
23. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
Kremer WW; Steenbergen R; Heideman D; Kenter GG; Meijer C
BJOG; 2021 Feb; 128(3):504-514. PubMed ID: 32619334
[TBL] [Abstract][Full Text] [Related]
24. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
25. Triage of human papillomavirus infected women by methylation analysis in first-void urine.
Van Keer S; van Splunter AP; Pattyn J; De Smet A; Herzog SA; Van Ostade X; Tjalma WAA; Ieven M; Van Damme P; Steenbergen RDM; Vorsters A
Sci Rep; 2021 Apr; 11(1):7862. PubMed ID: 33846517
[TBL] [Abstract][Full Text] [Related]
26. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
[TBL] [Abstract][Full Text] [Related]
27. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
28. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
29. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
[TBL] [Abstract][Full Text] [Related]
30. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
31. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
33. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
34. Urine human papillomavirus prevalence in women with high-grade cervical lesions.
Nicolau P; Mancebo G; Agramunt S; Solé-Sedeño JM; Bellosillo B; Muset MM; Lloveras B; Alameda F; Carreras R
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():12-5. PubMed ID: 25461344
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
36. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
[TBL] [Abstract][Full Text] [Related]
37. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
38. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
39. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
40. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment.
Stanczuk GA; Currie H; Baxter G; Foster A; Gibson L; Graham C; Cuschieri K
J Clin Pathol; 2015 Jul; 68(7):567-70. PubMed ID: 25878328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]